Utpal Koppikar - 08 Jun 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Chief Financial Officer
Signature
/s/ David Tucker, Attorney-in-Fact for Utpal Koppikar
Issuer symbol
ATRA
Transactions as of
08 Jun 2022
Net transactions value
-$32,952
Form type
4
Filing time
10 Jun 2022, 16:20:41 UTC
Previous filing
19 May 2022
Next filing
18 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale $32,952 -5,853 -2.8% $5.63 203,529 08 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
F2 Includes 1,790 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2022.